Eyetech to Announce First Quarter 2005 Financial Results on April 20, 2005

Eyetech to Announce First Quarter 2005 Financial Results on April
20, 2005 


NEW YORK, April 7  /PRNewswire-FirstCall/ -- Eyetech Pharmaceuticals, Inc.
(NASDAQ:EYET), today announced that it plans to report first quarter 2005
financial results on Wednesday, April 20, 2005 after the U.S. financial markets
close.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20050407/EYETLOGO )

Eyetech's senior management will hold a conference call and webcast to discuss
the results and provide a company update on Thursday, April 21, 2005 at 8:30
a.m. Eastern Time, before the U.S. financial markets open.

Live audio of the conference call will be available to investors, members of
the news media and the general public by dialing 888-275-0218 (in the United
States) or 706-679-7756 (internationally).  A playback of the call will be
available through May 5, 2005 by dialing 800-642-1687, passcode 5170755 (in the
United States) or 706-645-9291, passcode 5170755 (internationally).  To access
the call by live webcast, please log on to the Investor Relations section of
our corporate website at http://www.eyetech.com/.  An archived version of the
webcast will be available at the same location through May 5, 2005.

About Eyetech Pharmaceuticals, Inc.

Eyetech Pharmaceuticals, Inc. is a biopharmaceutical company that specializes
in the development and commercialization of novel therapeutics to treat
diseases of the eye.  Eyetech's initial focus is on diseases affecting the back
of the eye.  Eyetech is commercializing and further developing Macugen(R)
(pegaptanib sodium injection) with Pfizer Inc for the treatment of neovascular
AMD.  Macugen is also being studied for other indications including diabetic
macular edema and retinal vein occlusion. 

http://www.newscom.com/cgi-bin/prnh/20050407/EYETLOGODATASOURCE: Eyetech
Pharmaceuticals, Inc.



CONTACT:  Glenn Sblendorio, Chief Financial Officer of Eyetech

Pharmaceuticals, Inc., [phone], fax, [phone],





Web site:  http://www.eyetech.com/ 

Copyright